电邮这篇文章 Cytokine Profile in Experimental Models of Critical Limb Ischemia in Rats
- 作者: Lykov A.1,2, Bondarenko N.1,2, Poveshchenko O.1,2, Kabakov A.1, Surovtseva M.1,2, Kim I.1,2, Kazakov O.1, Poveshchenko A.1,2, Yankaite E.1
-
隶属关系:
- Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
- E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
- 期: 卷 168, 编号 1 (2019)
- 页面: 150-155
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/242307
- DOI: https://doi.org/10.1007/s10517-019-04666-y
- ID: 242307
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
We studied the effect of intramuscular administration of a cellular product (mesenchymal stem cells, conditioned media, and erythropoietin) on cytokine levels in blood serum, conditioned media of bone marrow mononuclears, and calf muscles in Wistar rats with hind limb ischemia. It is shown that the cellular product reduces the proinflammatory background at the early stages of the experiment and increases the content proangiogenic factors.
作者简介
A. Lykov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk
N. Bondarenko
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk
O. Poveshchenko
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk
A. Kabakov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk
M. Surovtseva
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk
I. Kim
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk
O. Kazakov
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk
A. Poveshchenko
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; E. N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk; Novosibirsk
E. Yankaite
Research Institute of Clinical and Experimental Lymphology, Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences
Email: aplykov2@mail.ru
俄罗斯联邦, Novosibirsk
